Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer

被引：120

作者：

Faridi, Rabia ^{[1
]}

Zahra, Amreen ^{[1
]}

Khan, Khalida ^{[2
]}

Idrees, Muhammad ^{[1
]}

机构：

[1] Univ Punjab, Natl Ctr Excellence Mol Biol, Div Mol Virol, Lahore 53700, Pakistan

[2] Univ Punjab, Ctr Integrated Mt Res, Lahore 54590, Pakistan

来源：

VIROLOGY JOURNAL | 2011年 / 8卷

关键词：

PARTICLE VACCINE; RISK-FACTORS; HAPTOGLOBIN GENOTYPE; SUSTAINED EFFICACY; SEXUAL-BEHAVIOR; GENE-PRODUCT; YOUNG-WOMEN; INFECTION; TYPE-16; PREVALENCE;

D O I：

10.1186/1743-422X-8-269

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Human Papillomavirus (HPV) is the most common cause of cervical cancer. Cervical cancer being the second most common cancer after lung cancer, affecting women of different age groups; has a prevalence of about 20% in young sexually active women. Among different types of HPV, HPV16 the major strain causing this cancer and is sexually transmitted had been unnoticed for decades. Keeping in mind the multiple risk factors related with cervical cancer such as early age sexual activities, teenage pregnancies, smoking, use of oral contraceptives, having multiple sex partners, hormone replacement therapies and various other unknown factors lead to the onset of the disease. Awareness for various diagnostic procedures such as Pap smears screening prove to be an effective way in eradicating the oncogenic potential of HPV.

引用

页数：8

共 83 条

[1] Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean [J].

Almonte, Maribel ;

Albero, Ginesa ;

Molano, Monica ;

Carcamo, Cesar ;

Garcia, Patricia J. ;

Perez, Gonzalo .

VACCINE, 2008, 26 :L16-L36

[2] Cervical cancer screening programmes and policies in 18 European countries [J].

Anttila, A ;

Ronco, G ;

Clifford, G ;

Bray, F ;

Hakama, M ;

Arbyn, M ;

Weiderpass, E .

BRITISH JOURNAL OF CANCER, 2004, 91 (05) :935-941

[3]

Anttila A, 2007, COLLEGIUM ANTROPOL, V31, P17

[4] Cervical carcinoma and reproductive factors:: Collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies [J].

Appleby, P. ;

Beral, V. ;

de Gonzalez, A. Berrington ;

Colin, D. ;

Franceschi, S. ;

Green, J. ;

La Vecchia, C. ;

Peto, J. ;

Plummer, M. ;

Randi, G. ;

Sweetland, S. .

INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (05) :1108-1124

[5]

Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5

[6] Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas [J].

Baay, MFD ;

Quint, WGV ;

Koudstaal, J ;

Hollema, H ;

Duk, JM ;

Burger, MPM ;

Stolz, E ;

Herbrink, P .

JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (03) :745-747

[7] Human papillomavirus testing on self-sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs [J].

Bais, Aagje G. ;

van Kemenade, Folkert J. ;

Berkhof, Johannes ;

Verheijen, Rene H. M. ;

Snijders, Peter J. F. ;

Voorhorst, Feja ;

Babovic, Milena ;

van Ballegooijen, Marjolein ;

Helmerhorst, Theo J. M. ;

Meijer, Chris J. L. M. .

INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (07) :1505-1510

[8] Chronic inflammation, immunosuppression and cancer: New insights and outlook [J].

Baniyash, M .

SEMINARS IN CANCER BIOLOGY, 2006, 16 (01) :80-88

[9] Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands [J].

Bos, Anita B. ;

Rebolj, Matejka ;

Habbema, J. Dik F. ;

van Ballegooijen, Marjolein .

INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (10) :2372-2375

[10] The causal relation between human papillomavirus and cervical cancer [J].

Bosch, FX ;

Lorincz, A ;

Muñoz, N ;

Meijer, CJLM ;

Shah, KV .

JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (04) :244-265

← 1 2 3 4 5 6 7 8 9 →